Shu Ning
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 12
-
- Prostate Cancer Treatment and Research 13
- Co-authors
- Chung Shu Yang (18 shared papers)John F. Brady (7 shared papers)Christopher Patten (2 shared papers)Anthony Y.H. Lu (1 shared paper)Paul E. Thomas (4 shared papers)Mong-Heng Wang (2 shared papers)Jun-Yan Hong (3 shared papers)Mao‐Jung Lee (4 shared papers)
- Journals
- Molecular Cancer Therapeutics (4 papers)Archives of Biochemistry and Biophysics (4 papers)Oncogene (3 papers)Toxicology and Applied Pharmacology (3 papers)Archives of Toxicology (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Shu Ning
40 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 85
- Pharmacology 647
- Biochemistry 197
- Cancer Research 224
- Pathology and Forensic Medicine 207
- Oncology 274
Countries citing papers authored by Shu Ning
This map shows the geographic impact of Shu Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Ning more than expected).
Fields of papers citing papers by Shu Ning
This network shows the impact of papers produced by Shu Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Ning. The network helps show where Shu Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Shu Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 130 | |
| 2 | 1991 | 123 | |
| 3 | 1991 | 111 | |
| 4 | 1991 | 99 | |
| 5 | 1990 | 70 | |
| 6 | Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. | 1993 | 70 |
| 7 | 1992 | 67 | |
| 8 | Metabolism of carcinogenic nitrosamines by rat nasal mucosa and the effect of diallyl sulfide. | 1991 | 65 |
| 9 | 2020 | 64 | |
| 10 | 1990 | 60 | |
| 11 | 1993 | 58 | |
| 12 | Regulation of N-nitrosodimethylamine demethylase in rat liver and kidney. | 1987 | 55 |
| 13 | 1989 | 50 | |
| 14 | Metabolism and activation of N-nitrosodimethylamine by hamster and rat microsomes: comparative study with weanling and adult animals. | 1987 | 49 |
| 15 | 1990 | 45 | |
| 16 | 1992 | 42 | |
| 17 | Molecular basis for the sex-related difference in renal N-nitrosodimethylamine demethylase in C3H/HeJ mice. | 1989 | 39 |
| 18 | 1992 | 39 | |
| 19 | 1990 | 29 | |
| 20 | 2021 | 21 |
About Shu Ning
Shu Ning is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Pharmacogenetics and Drug Metabolism (12 papers), PARP inhibition in cancer therapy (4 papers), Epigenetics and DNA Methylation (4 papers), Chemical Reactions and Isotopes (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Pharmacology (647 citations), Biochemistry (197 citations), Cancer Research (224 citations), Pathology and Forensic Medicine (207 citations) and Oncology (274 citations). Shu Ning has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Chung Shu Yang, John F. Brady, Christopher Patten, Anthony Y.H. Lu, Paul E. Thomas, Mong-Heng Wang, Jun-Yan Hong, Mao‐Jung Lee, Theresa J. Smith and Eugene J. Pantuck. Their work appears in journals such as Molecular Cancer Therapeutics, Archives of Biochemistry and Biophysics, Oncogene, Toxicology and Applied Pharmacology and Archives of Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.